The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.
The FDA has approved the first new class of schizophrenia drug in 70 years Australian science contributed to the discovery of ...
The US FDA has approved a new drug, Cobenfy, for treating schizophrenia in adults. This is a first new class for medication ...
Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer ...
The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), making it the first major ...
FARGO, N.D. (Valley News Live) - Changes are coming to the way schizophrenia is treated. The US Food and Drug Administration ...
PureTech Health has obtained approval from the US Food and Drug Administration (FDA) for KarXT to treat schizophrenia in ...
Recent research is painting a clearer picture of the link between the use of clozapine for schizophrenia and respiratory ...
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of ...
The US Food and Drug Administration (FDA) has approved xanomeline and trospium chloride capsules (Cobenfy) for the treatment of schizophrenia in adults. The drug is the first antipsychotic treatment ...
New drug for schizophrenics has experts excited Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. "This drug takes ...